New patent expiration for United Therap drug REMODULINBy DrugPatentWatch – Make Better Decisions / May 24, 2024 Annual Drug Patent Expirations for REMODULIN Remodulin is a drug marketed by United Therap and is included in two NDAs. It is available from one supplier. There are ten patents…Source